Four Tree Island Advisory’s AbbVie ABBV Stock Holding History

Four Tree Island Advisory’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$736K	Buy	3,384 +60	+2%	+$13.3K	0.37%	17
2025 Q4	$760K	Hold	3,324	–	–	0.42%	15
2025 Q3	$766K	Hold	3,324	–	–	0.49%	16
2025 Q2	$1.68M	Sell	3,324 -58	-2%	-$10.8K	1.18%	13
2025 Q1	$709K	Sell	3,382 -17,576	-84%	-$3.42M	0.5%	16
2024 Q4	$3.72M	Buy	+20,958	New	+$3.85M	2.57%	10

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Four Tree Island Advisory's ABBV Position: Q1 2026 in Review

Four Tree Island Advisory increased its AbbVie (ABBV) stake by 1.8% in Q1 2026, buying an estimated $13.3K and bringing the position to 3,384 shares worth $736K. The position accounts for 0.37% of the portfolio, ranked #17.

Four Tree Island Advisory first reported a position in ABBV in Q4 2024 and has held it in 6 quarters since. The position peaked at $3.72M in Q4 2024. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Four Tree Island Advisory held 3,384 shares of AbbVie worth $736K as of Q1 2026.
Four Tree Island Advisory bought 60 AbbVie shares in Q1 2026, an estimated $13.3K.
AbbVie made up 0.37% of Four Tree Island Advisory's portfolio in Q1 2026, its #17 holding.
Four Tree Island Advisory first reported a position in AbbVie in Q4 2024 and has held it in 6 quarters since.
Four Tree Island Advisory's AbbVie position peaked at $3.72M in Q4 2024.
4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Four Tree Island Advisory's 13F filing for Q1 2026, filed 11 May 2026.